Apellis Pharmaceuticals Inc

NASDAQ:APLS   1:00:00 PM EDT
50.96
+1.47 (+2.97%)
: $49.44 -1.52 (-2.98%)
Earnings Announcements

Apellis Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:23 GMT
Apellis Pharmaceuticals Inc (APLS) - Apellis Pharmaceuticals Reports Third Quarter 2022 Financial Results.
Apellis Pharmaceuticals Inc - Cash and Investments of $708.6 Million As of Sept.
30, 2022; Expected Cash Runway Into Q1 2024.
Apellis Pharmaceuticals Inc - Qtrly Loss per Share $1.75.
Revenue is expected to be $24.82 Million
Adjusted EPS is expected to be -$1.49

Next Quarter Revenue Guidance is expected to be $29.59 Million
Next Quarter EPS Guidance is expected to be -$1.52

More details on our Analysts Page.